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Highlights  
 
- TpeL is a cytotoxin produced by Clostridium perfringens which belongs to the large 
clostridial glucosylating toxin family 
 
- TpeL uses both UDP-glucose and UDP-N-acetylglucosamine as cosubstrates but preferentially 
this latter. 
 
- TpeL modifies mainly cH-Ras, N-Ras, K-Ras and to a lower extent Rap1a,  R-Ras3, and Rac1 
 
- TpeL modifies cH-Ras at Thr35 
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Abstract 
 TpeL is a toxin produced by Clostridium perfringens which belongs to the large 
clostridial glucosylating toxin family. It was shown that TpeL modifies Ras using UDP-
glucose or UDP-N-acetylglucosamine as cosubstrates (Guttenberg et al., 2012; Nagahama et 
al., 2011). We confirmed that TpeL preferentially glucosaminates the three isoforms of Ras 
(cH-Ras, N-Ras, and K-Ras) from UDP-N-acetylglucosamine and to a lower extent Rap1a 
and R-Ras3, and very weakly Rac1. In contrast to previous report, we observed that Ral was 
not substrate of TpeL. In addition, we confirmed by in vitro glucosylation and mass 
spectrometry that TpeL modifies cH-Ras at Thr35. 
 
1.  Introduction 
 Clostridium perfringens is an ubiquitous anaerobic bacterium which is responsible for 
mild to severe diseases in humans (gas gangrene, gastrointestinal diseases) and animals 
(mainly gastrointestinal and enterotoxemic diseases). The pathogenicity of this 
microorganism is based on protein toxins, which are secreted in the culture medium, 
gastrointestinal tract or tissues (Popoff and Bouvet, 2009). C. perfringens is among the 
bacteria which produce the greatest number of toxins. According to the toxins, which are 
synthesized, C. perfringens strains are divided into several toxinotypes (Petit et al., 1999). 
Recently, a new toxin, called TpeL (for toxin C. perfringens large cytotoxin), was identified 
in several strains of C. perfringens type B and C. TpeL was found to be lethal for mice and 
cytotoxic for Vero cells and shows a significant homology of its N-terminal region with the 
catalytic domain of the large glucosylating clostridial toxins which encompass Clostridium 
difficile toxin A (TcdA) and toxin B (TcdB), Clostridium sordellii lethal toxin (TcsL) and 
hemorrhagic toxin (TcsH), and Clostridium novyi alpha toxin (TcnA) (Amimoto et al., 2007). 
 Large glucosylating clostridial toxins (LGCTs) contain at least three functional 
domains. The one third C-terminal part exhibits multiple repeated sequences (31 short repeats 
and 7 long repeats in TcdA), which are involved in the recognition of a cell surface receptor. 
The central part contains a hydrophobic segment and probably mediates the translocation of 
the toxin across the membrane. The enzymatic site characterized by the DxD motif 
surrounded by a hydrophobic region, and the substrate recognition domain are localized 
within the 543 N-terminal residues corresponding to the natural cleavage site in TcdB 
(Hofmann et al., 1998; Hofmann et al., 1997; Rupnik et al., 2005). The overall structure of 
the enzymatic domains of TcdB, TcsL and TcnA is conserved and consists of a -strain 
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 3 
central core (about 235 amino acids) forming an active center pocket surrounded by numerous 
-helices (Jank and Aktories, 2008; Reinert et al., 2005; Ziegler et al., 2008). LGCTs catalyze 
the glucosylation of Rho- and/or Ras-GTPases from UDP-glucose, except TcnA, which uses 
UDP-N-acetylglucosamine as cosubstrate. The glucosylating activity supports the main 
biological activities of these toxins. But, LGCTs differ in their substrates. Thereby, TcdA and 
TcdB glucosylate Rho, Rac and Cdc42 at Thr-37, whereas LcsT glucosylates Ras at Thr-35, 
Rap, Ral and Rac at Thr-37 (Just and Gerhard, 2004; Popoff and Bouvet, 2009). The 
structural basis of the different recognition of substrates is not well known. Differences in -
helices, insertions-deletions, probably account for the substrate specificity of each toxin 
(Reinert et al., 2005; Ziegler et al., 2008). Chimeric molecules between TcdB and TcsL have 
been used to identify the sites of Rho-GTPase recognition. Amino acids 408 to 468 of TcdB 
ensure the specificity for Rho, Rac and Cdc42, whereas in TcsL, the recognition of Rac and 
Cdc42 is mediated by residues 364 to 408, and that of Ras proteins by residues 408 to 516 
(Hofmann et al., 1998; Jank et al., 2007). Since TpeL seems to be a natural variant of large 
glucosylating clostridial toxins, the characterization of its enzymatic activity and substrate 
specificity would permit to better understand the structure/function of this group of toxins. 
 In this study, we show that TpeL is a glucosylating toxin which targets Ras proteins 
and to a lower extent Rap and R-Ras3, and preferentially uses UDP-N-acetylglucosamine as 
cosubstrate. Similarly to C. sordellii TcsL, TpeL monoglucosylates Ras at Thr35. During the 
progress of this work, related results have been published (Guttenberg et al., 2012). 
 
2. Materials and methods 
2.1 Reagents 
 Uridine-5-diphospho(UDP)-glucose, UDP-N-acetylglucosamine, UDP-galactose, 
UDP-glucuronic acid, UDP-galacturonic acid, UDP-mannose, ADP-glucose, ADP-ribose, 
CDP-glucose, GDP-glucose, TDP-glucose were from Sigma. Plasmids encoding Rho-, Rac-, 
Cdc42-GST proteins were from A. Hall. 
 
2.2 Production and purification of recombinant TpeL N-terminus (rN-TpeL) 
 The DNA coding for the N-terminal part of TpeL was PCR amplified from C. 
perfringens type B strain NCTC3181 with primers adding a BamHI site at the 5' end and a 
SalI site at the 3' end. The PCR product was cloned into pCR2.1 vector (Invitrogen), and the 
digested insert with BamHI-SalI was subcloned into pET28a (Novagen) at the corresponding 
sites. The recombinant protein was fused to an N-terminal extension containing a 6-histidine 
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 4 
motif from pET28.  
 E. coli BL21 CodonPlus (DE3)-RIL (Stratagene) transformed with recombinant 
plasmids respectively were grown in LB medium containing kanamycine (50 g/ml) at 26° C 
until a OD of 0.8. The expression was induced with IPTG (1 mM) and growth was continued 
overnight at 26° C. The bacteria were harvested by centrifugation, suspended in lysis buffer 
(50 mM Hepes, pH 7.5, 150 mM NaCl, and protease inhibitors (Calbiochem), and sonicated. 
The cell debris were separated from the soluble fraction by centrifugation (18000g, 15 min). 
The soluble fraction was applied on a cobalt column (Talon, Qiagen). The column was 
washed with lysis buffer, and eluted with 2, 10 and 100 mM imidazole in the same buffer. 
The fractions containing highly purified recombinant proteins were pooled and dialyzed 
against 20 mM Hepes, pH 7.5, 150 mM NaCl. 
 
2.3 In vitro glucosylation 
 Glucosylation of small GTPases was achieved as followed according to (Popoff et al., 
1996). 2 l of UDP-[
14
C]Glucose or UDP-[
14
C]-N-acetylglucosamine in ethanol (O.2 Ci, 
300 mCi/mmol; DuPont NEN, les Ulis France) was dried under vacuum; 1 g of GST-
GTPase protein in a final volume of 20 l of glucosylation buffer (50 mM triethanolamine pH 
7.5, 2 mM MgCl2, 0.3 mM GDP ) were added to the dried UDP-[
14
C]Glucose. One l of rN-
TpeL (2 mg/ml) was added to start the reaction, which was carried out for 1 h at 37°C. The 
reaction was stopped by adding 5 l of 2 x SDS sample buffer, boiled and electrophoresed on 
a 15% SDS-polyacrylamide gel. After staining with Coomassie blue, followed by distaining, 
the gel was dried and autoradiographed. 
 
2.4 Peptide analysis by HPLC, sequencing and mass spectrometry 
 cH-Ras (5 g) was incubated without or with rN-TpeL (10
-7
 M) in glucosylation 
buffer containing UDP-N-acetylglucosamine (5 mM) for 3 h at 37°C. Ras was the subjected 
to SDS-(14%)PAGE and stained with Amido Black. Ras bands were cut from the gel, washed 
with distilled water, dried, and resuspended in 150 l of 50 mM Tris-HCl (pH 8.6) containing 
0.001% Tween 20 and 0.2 g of trypsin (Promega). Following18 h at 30°C, the preparations 
were centrifuged, the pellets were washed with 100 l of 50 mM Tris-HCl (pH 8.6) 
containing 0.05% SDS and then with 100 l 60% acetonitrile. The supernatants were 
recovered and concentrated to 100 l by Speed Vac. Samples were injected onto a DEAE-
HPLC column (Interchim Hema Bio 1000 DEAE, 33 x 1 mm) linked to a C18 reverse phase 
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 5 
HPLC column (Interchim Uptisphere ODBD, 150 x 1 mm) eluted with 2-70% acetonitrile 
gradient in 0.1% trifluoroacetic acid and monitored at 214 nm.  
Separated peptides (1-2 l on a ProteinChip gold array) were identified by their mass 
using SELDI-TOF-MS (PCS4000) from Bio-Rad (focus mass = 4000 daltons; laser intensity 
= 1100 nl). The matrix was -cyano-4-hydoxycinnamic acid saturated in 50% acetonitrile, 
0.5% trifluoroacetic acid. 
 
2.5 MS and MS/MS analysis 
Purified HPLC fractions were diluted in 10 µl of CHCA matrix (5 mg/ml in 70% ACN 
/ 30 % H2O / 0.1 % TFA) and 0.5 µl of them were spotted on the MALDI plate.  
MS spectra were acquired in reflector positive mode using the 4800 MALDI 
TOF/TOF Analyzer (Applied Biosystems, USA) within a mass range of 800 to 4000 m/z. MS 
calibration was first carried out to a final mass accuracy of 1 ppm with a mixture of 5 standard 
peptides: des-Arg1 Bradykinin, M+H
+
=904.468; Angiotensin, M+H
+
=1296.685; Glu1-
Fibrinopeptide, M+H
+
=1570.677; ACTH 1-17, M+H
+
=2093.087; ACTH 18-39, 
M+H
+
=2465.199. MS spectra of the purified fractions were then acquired (3000 laser shots 
were averaged) and calibrated using the external default calibration (10 ppm mass accuracy). 
MS/MS were performed in CID positive ion mode with a 2 kV collision energy of and 
air as collision gas. MS/MS calibration was performed using 4 CID fragments of the Glu1-
Fibrinopeptide (M+H
+
= 175.119, 684.346, 1056.475 and 1441.634) (mass accuracy of 10 
ppm). 4000 to 10 000 laser shots were averaged to acquired MS/MS spectra of the selected 
precursors. Each spectrum was then calibrated using the external default calibration (mass 
accuracy of 100 ppm). 
MS/MS queries were performed using the MASCOT search engine 2.1 (Matrix 
Science Ltd., UK) and the SwissProt 57.4 database (470369 sequences; 166709888 residues) 
with the following parameters: 50 ppm mass tolerance for the precursor and 0.3 Da for 
MS/MS fragments, trypsin cleavage. Hexose-N-acetylglucosamine (HexNAc) and oxidation 
of methionins were used as variable modifications. In these conditions, the minimal 
MASCOT score was 28 for a peptide confidence index ≥ 95%. 
 
3. Results 
 
3.1 TpeL is a glucosyltransferase which targets Ras proteins 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 6 
 As previously found (Amimoto et al., 2007), TpeL shows a significant overall 
sequence homology with the LCGTs and contains a conserved active enzymatic site (DxD) in 
the N-terminal part, except that the total protein length is shorter (190 kDa) than that of the 
glucosylating toxins from C. difficile, C. sordellii or C. novyi (250 to 300 kDa) (Jank and 
Aktories, 2008; Just and Gerhard, 2004; Popoff and Bouvet, 2009; Rupnik and Just, 2006). 
The N-terminal domain (amino acid 1 to 543) of LCGTs is the intracellular active domain, 
which is released into the cytosol through an autoproteolytic process during the toxin 
endocytosis (Jank and Aktories, 2008). Interestingly, the TpeL N-terminal domain shows a 
high level of sequence similarity with that of the other LCGTs with an intermediate position 
between the N-terminal domain of C. novyi alpha toxin and those of the C. difficile and C. 
sordellii glucosylating toxins (Fig. 1). Therefore, we produced and purified the N-terminal 
domain of TpeL as recombinant protein (Fig. 3) to check its enzymatic activity. In a first 
series of experiments we used Rho, Rac, Cdc42 and cH-Ras, which are the representative 
substrates of LGCTs, in a glucosylation assay with TpeL. As shown in Fig. 2B, TpeL N-
terminus glucosylated only cH-Ras and no RhoA, Rac1 or Cdc42. In addition, the 
glucosylation of cH-Ras was more efficient by using UDP-N-acetylglucosamine than UDP-
glucose as cosubstrate. Thereby, recombinant TpeL N-terminal part contains a 
glucosyltransferase activity specific of cH-Ras protein but not of Rho and Cdc42. 
 
3.2 TpeL preferentially uses UDP-N-acetylglucosamine as cosubstrate 
 In order to determine the cosubstrate requirement for TpeL (10
-7
 M) activity, kinetics 
of cH-Ras glucosylation was performed in the presence of UDP-[
14
C]-glucose or UDP-[
14
C]-
N-acetylglucosamine (Fig. 3 A). An almost complete glucosylation of cH-Ras was obtained 
with TpeL in the presence of UDP-[
14
C]-N-acetylglucosamine, whereas the reaction with 
UDP-[
14
C]-glucose had longer kinetics (Fig. 3A and B). The level of cH-Ras glucosylation 
was about 100 fold less with UDP-glucose compared to UDP-N-acetylglucosamine. Even 
after longer incubation period (until 2 h), a 100-fold difference in enzymatic level was 
observed between both cosubstrates (not shown). 
 Then, we investigated if UDP-N-acetylglucosamine was the only efficient cosubstrate 
of TpeL by a competition assay using cH-Ras, UDP-[
14
C]-N-acetylglucosamine, and various 
non-radioactive hexose derivatives. As expected, non-radioactive UDP-N-acetylglucosamine 
totally blocked the transfer of [
14
C]-N-acetylglucosamine from UDP-[
14
C]-N-
acetylglucosamine on cH-Ras, whereas N-acetylglucosamine was inefficient (Fig. 3C and D). 
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 7 
UDP-glucose and UDP-mannose, a close isoform of UDP-glucose, were also as efficient as 
UDP-N-acetylglucosamine to block the TpeL-dependent glucosylation of cH-Ras. The other 
UDP derivatives (UDP-galactose, UDP-glucuronic acid, and UDP-galacturonic acid) also 
inhibited the glucosylation of cH-Ras but to a lower extent. Among the other nucleoside-
diphosphate hexose derivatives, GDP-glucose partially prevented cH-Ras glucosylation. TDP-
glucose which contains a pyrimidine base as UDP, was not effective to compete the reaction. 
This suggests that UDP is a major structure which is recognized by TpeL. 
 
3.3 Ras is the main substrate of TpeL 
 Next, we investigated the substrates of TpeL. Using a large set of recombinant small 
GTPases and UDP-N-acetylglucosamine as cosubstrate, we checked the TpeL activity in the 
in vitro glucosylation assay. As shown in Fig. 4A, Ras proteins including cH-Ras, K-Ras, and 
N-Ras were the main substrates which were efficiently glucosylated by TpeL. In addition, R-
Ras3 and Rap1a, which also belong to the Ras family of proteins, were glucosylated by TpeL, 
but to a lower extent. The glucosylation level of R-Ras3 was 16% from that of Ras, and that 
of Rap1a 6% (Fig. 4B). No proteins from the Rho family nor Rab6 and Arf1, representative 
proteins from the Rab and Arf families, were substrates of TpeL, except Rac1 which was very 
weakly modified compared to cH-Ras (Fig. 4A). Thereby, TpeL contains a 
glucosyltransferase activity targeting Ras proteins, and predominantly cH-Ras, K-Ras, and N-
Ras. 
 
3.4 TpeL glucosylates cH-Ras at Thr35 
 In an effort to identify the cH-Ras residue or residues that are modified by TpeL, cH-
Ras (5 g) was incubated with TpeL (10
-7
 M), non-radioactive UDP-N-acetylglucosamine (10 
mM) in glucosylation buffer during 3 h at 37°C and then analyzed by SELDI-TOF using a 
Q10 chip (strong anionic exchanger). cH-Ras prepared in the same conditions but without 
TpeL was used as reference. As shown in Fig. 5, cH-Ras treated with TpeL in the presence of 
UDP-N-acetylglucosamine has an increase in mass of 205, which correlates with an addition 
of a one HexNAc molecule (MW 203). This indicates that TpeL catalyzes the transfer of one 
HexNAc molecule per cH-Ras molecule. 
 Next, cH-Ras treated with rN-TpeL or untreated was run on a SDS-PAGE, trypsin 
digested, and the resulting peptides were separated by HPLC. As shown in Fig. 6A, fraction 
14 from rN-Tpel-treated cH-Ras has an increased retention time which corresponds to an 
increased mass of 203 daltons compared to fraction 15 of untreated cH-Ras as determined by 
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 8 
SELDI-TOF (Fig. 6B). N-terminal sequencing of fractions14 and 15 showed that the peptides 
with the sequence SALT and SALTIQ, respectively. This indicates that fraction 14 from rN-
TpeL treated cH-Ras and fraction 15 from untreated cH-Ras contained the same trypsin 
cleavage peptide SALTIQLIQNHFVDEYDPTIEDSYR. These results show that the residue 
modified by rN-TPEL and resulting from an addition of an HexNAc is part of the peptide 
SALTIQLIQNHFVDEYDPTIEDSYR which contains two Thr residues. 
 Fractions 14 and 15 were further analyzed by MS and MSMS followed by MASCOT 
searching (Fig. 7 and supplementary Fig. 1 and 2). HexNAc modification was identified on 
Thr19 of the peptide which corresponds to Thr35 of cH-Ras. 
 
4. Discussion 
 It is reported that TpeL is produced by several C. perfringens types including types A, 
B and C and its gene localization on plasmid accounts for horizontal transfer between C. 
perfringens strains (Amimoto et al., 2007; Sayeed et al., 2010). TpeL synthesis seems to be 
dependent of the sporulation (Paredes-Sabja et al., 2011) and this novel toxin likely represents 
an additional virulence factor involved in necrotic enteritis in poultry (Coursodon et al., 
2012). Indeed, TpeL is cytotoxic to various cell lines by inducing apoptosis via impairment of 
the Ras signaling pathway (Guttenberg et al., 2012). However some C. perfringens strains, 
like MC18, seems to contain a truncated tpel gene resulting in a protein lacking 128 C-
terminal amino acids which is not cytotoxic (Guttenberg et al., 2012). In our experience, only 
a few C. perfringens strains type C isolated from necrotic enteritis in piglets, and a C. 
perfringens type A strain isolated from food contain tpel gene.  
TpeL is related to the LCGTs based on amino acid sequence identity and shows the 
highest similarity with TcnA. We have analyzed the enzymatic properties of TpeL, from 
which most of them have been published during the progress of this work (Guttenberg et al., 
2012; Nagahama et al., 2011). Albeit confirmatory in a large part, our investigations bring 
complementary data. TpeL is a glucosytransferase, which retains the enzymatic site DxD of 
LCGTs and with a global amino acid sequence identity more related to TcnA than to the other 
LCGTs (Fig. 1). In addition, TpeL displays the same motif, A383NQ385, of co-substrate 
specificity than TcnA, which uses UDP-N-acetylglucosamine as sugar donor, instead of 
I383NQ385 in the other LCGTs which catalyzes the transfer of glucose from UDP-glucose 
(Guttenberg et al., 2012). Using the recombinant catalytic domain (1-543), we showed that 
TpeL exhibited both UDP-glucosylation and UDP-N-acetylglucosamination (GlcNAcylation) 
activities towards cH-Ras, but with a 100 fold more efficiency of GlcNAcylation. UDP is the 
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major binding determinant since the rN-TpeL GlcNAcylation was impaired by all UDP-
hexoses tested in competition assay (Fig. 3C and D). However, UDP-glucose and UDP-N-
acetylglucosamine were more efficient competitors than the other UDP-hexoses, indicating a 
stringent specificity for these two cosubstrates. In contrast, Nagahama et al. report a TpeL 
enzymatic competition only with UDP-glucose and UDP-N-acetylglucosamine and no with 
other UDP-hexoses (Nagahama et al., 2011). The bases of these discrepant results are not 
clear, in our study, the recombinant N-terminal TpeL 1-543 amino was used instead TpeL 1-
525 by Nagahama et al. (Nagahama et al., 2011). 
As previously found, the three isoforms of Ras including cH-Ras, N-Ras and K-Ras 
are the main substrates of Tpel. Using a large panel of small GTPases, we observed that  rN-
TpeL modified cH-Ras, N-Ras and K-Ras and to a lower extent Rap1a and R-Ras3. In 
contrast to previous findings [Guttenberg, 2012 #3074;Nagahama, 2011 #3076], we showed 
that Rac1 was a very poor substrate of TpeL in the presence of UDP-N-acetylglucosamine. 
Only a weak glucosamination was evidenced after a long exposure of the autoradiographies 
and no Rac glucosylation was observed with rN-TpeL and UDP-glucose. In agreement with 
Guttenberg et al. (Guttenberg et al., 2012) we showed no modification of Ral by TpeL in the 
presence of UDP-N-acetylglucosamine or UDP-glucose, whereas Ral has been reported to be 
a TpeL substrate by Nagahama and coworkers (Nagahama et al., 2011). These different 
observations might result from the distinct recombinant TpeL fragments used in each study. 
We confirmed by in vitro glucosylation and mass spectrometry thet TpeL modifies Ras at 
Thr35. In our conditions, TpeL displays glucosyltransferase activity only with Ras proteins, 
mainly the three isoforms of Ras and weakly Rap1a and R-Ras3, and is not active with Rho 
proteins. This opens the way to delineate specific tools directed towards Ras for therapeutic 
purpose and cell biology investigations. 
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Figure legends 
 
Figure 1. Phylogenetic tree of the whole toxin sequence (A) and enzymatic domain (543 N-
terminal amino acids) (B) of TpeL (AB262081), TcdA (YP_001087137), TcdB (CAJ67492), 
TcdBF (CAC19891), TcsL6018 (X82638) and TcnA (CAA88565.1) according to the UP-
GMA method. The percentage of replicate trees in which the associated taxa clustered 
together in the bootstrap test (100 replicates) are shown next to the branches. The tree is 
drawn to scale, with branch lengths in the same units as those of the evolutionary distances 
used to infer the phylogenetic tree. The evolutionary distances were computed using the 
Poisson correction method and are in the units of the number of amino acid substitutions per 
site. 
 
Figure 2. TpeL N-terminal part glucosylates Ras but not Rho, Rac, and Cdc42. (A) SDS-
PAGE of recombinant N-terminal part of TpeL stained with Blue Coomassie R-250. (B) 
Glucosylation of Ras, Rho, Rac, or Cdc42 (1 g recombinant protein) by TpeL N-terminal 
part (10
-7
 M) in the presence of UDP-[
14
C]Glucose or UDP-[
14
C]-N-acetylglucosamine for 1 h 
at 37°C. The proteins were run on a SDS-PAGE and autoradiographed.  
 
Figure 3. TpeL uses preferentially UDP-N-acetylglucosamine as cosubstrate. A kinetics of 
Ras glucosylation by rN-TpeL. Ras (1 g) was incubated with rN-TpeL (10
-7
 M) for 1, 5, 10, 
15 or 30 min at 37°C in glucosylation buffer containing 7 M UDP-[
14
C]-N-
acetylglucosamine or UDP-[
14
C]-glucose. The samples were electrophoresed on a SDS-
(14%)PAGE, autoradiographed, and band intensity was quantified by ImageJ (NIH, USA). 
Experiments were done in triplicate. Means +/_ standard deviation are shown. (B) Kinetics of 
Ras glucosylation by rN-TpeL with UDP-[
14
C]-glucose as in A but with a different scale of Y 
axis. Note that Ras glucosylation with UDP-[
14
C]-glucose is about 100 fold less than with 
UDP-[
14
C]-N-acetylglucosamine. (C) Competition assay of Ras glucosylation with various  
hexose derivatives. Ras (1 g) was incubated in glucosylation buffer with rN-Tpel (10
-7
 M) 
and each of the various hexose derivatives (5 mM) for 30 min at 37°C. Then UDP-[
14
C]-N-
acetylglucosamine was added and the preparations were incubated at 37°C for additional 30 
min and processed as described above. (D) Quantification of the competition assays. 
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Figure 4. TpeL recognizes specifically Ras. (A) Glucosylation of recombinant small GPTases 
(1 g) with rN-Tpel (10
-7
 M) and UDP-[
14
C]-N-acetylglucosamine was performed as 
described in Experimental Procedures for 1 h at 37°C. (B) Quantification of the glucosylated 
small GTPases. Glucosylation of Ras was defined as 100%. 
 
Figure 5. Mono-N-acetylglucosaminylation of cH-Ras by TpeL. cH-Ras untreated and treated 
by rN-TpeL (10
-7
 M) in glucosylation buffer containing 5 mM UDP-N-acetylglucosamine for 
3 h at 37°C was analyzed by SELDI-TOF mass spectrometry with a Q10 array. Ras treated 
with rN-TpeL shows an increased mass of 205 Da. 
 
Figure 6. Identification of Ras peptide containing the TpeL modification. (A) Ras untreated 
and treated by rN-TpeL (10
-7
 M) in glucosylation buffer containing 5 mM UDP-N-
acetylglucosamine for 3 h at 37°C was trypsin digested and analyzed by HPLC on a DEAE 
column linked to a C18 reverse phase column. Fraction 15 from untreated Ras and fraction 14 
from rN-TpeL treated Ras were found to contain the same peptide 
SALTIQLIQNHFVDEYDPTIEDSYR by N-terminal sequencing,. (B) SELDI-TOF mass 
spectrometry showing that the peptide from fraction 14 (rN-TpeL-treated Ras) has an 
increased mass of 203 Da versus that of the parental peptide (fraction 15) from untreated Ras. 
 
Figure 7. TpeL mono-N-acetylglucosaminates Ras at Thr35. MS and MS-MS spectrum of 
fraction 14 from rN-TpeL-treated Ras (A) and fraction 15 from untreated Ras (B). 
 
Supplementary Figure 1. Mascot search results of MS-MS residues of peptide from fraction 
14 (rN-TpeL-treated Ras). 
 
Supplementary Figure 2. Mascot search results of MS-MS residues of peptide from fraction 
15 (untreated Ras). 
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